Hostname: page-component-7bb8b95d7b-2h6rp Total loading time: 0 Render date: 2024-09-13T20:59:23.415Z Has data issue: false hasContentIssue false
  • English
  • Français

Lewy Body Dementia Without Alzheimer Changes

Published online by Cambridge University Press:  18 September 2015

A.A.F. Sima ,
A.W. Clark ,
N.A. Sternberger  and
L.A. Sternberger
A.A.F. Sima*
Affiliation:
Section of Neuropathology, Department of Pathology, Health Sciences Centre, Winnipeg
A.W. Clark
Affiliation:
Department of Pathology, Foothills Hospital, Calgary
N.A. Sternberger
Affiliation:
Center for Brain Research, University of Rochester School of Medicine, Rochester, N.Y.
L.A. Sternberger
Affiliation:
Center for Brain Research, University of Rochester School of Medicine, Rochester, N.Y.
*
Health Sciences Centre, MS459A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Three patients with clinical Alzheimer's disease were found at postmortem examination to have Lewy-bodies and Lewy-like bodies in the cerebral cortex and the pigmented brainstem nuclei. Neuritic plaques were found in neocortical areas but no neurofibrillary tangles. The distribution of cortical neuronal inclusions correlated with the proposed projection of dopamine terminals. Neuronal cell loss was marked in the ventral tegmental area (paranigral nucleus) and the basal nucleus of Meynert, suggesting a defect in dopaminergic and cholinergic innervation of the cerebral cortex. Immunohistochemical investigations revealed positive staining of cortical Lewy- and Lewy-like bodies for monoclonal antibodies to phosphorylated neurofilaments (03-44, 06-17, 04-7). Also cerebral neurons containing no inclusions showed positivity, suggesting an early neurofilament abnormality, preceding the formation of Lewy-type inclusions.

Type
Cellular Clues to Pathogenesis
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue S4 , November 1986 , pp. 490 - 497
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

1.Woodard, JS. Concentric hyalin inclusion body formation in mental disease. Analysis of 27 cases. J Neuropath Exp Neurol 1962; 21: 442–449.CrossRefGoogle Scholar
2.Kosaka, K, Oyanagi, S, Matsushita, M, et al. Presenile dementia with Alzheimer-, Pick- and Lewy body changes. Acta Neuro-pathol (Berl) 1976; 36: 221–233.CrossRefGoogle ScholarPubMed
3.Forno, LS, Barbour, PJ, Norville, RL. Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 1978; 35: 818–822.CrossRefGoogle ScholarPubMed
4.Kosaka, K, Yoshimura, M, Ikeda, K, et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree — a new disease? Clin Neuropath 1984; 3: 185–192.Google ScholarPubMed
5.Yagashita, S, Itoh, Y, Amano, N, etal. Atypicalseniledementiawith widespread Lewy-type inclusion in the cerebral cortex. Acta Neuropath. (Berl) 1980; 49: 187–191.CrossRefGoogle Scholar
6.Yoshimura, M. Cortical changes in the Parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease”.J Neurol 1983; 229: 17–32.CrossRefGoogle Scholar
7.Vuia, O. Neuroaxonal dystrophy, ajuvenile adult form. Clin Neurol Neurosurg 1977; 79: 305–315.Google Scholar
8.Williamson, K, Sima, AAF, Curry, B, Ludwin, SK. Neuroaxonal dystrophy in young adults: A clinicopathologic study of two unrelated cases. Ann Neurol 1982; 11: 335–343.CrossRefGoogle ScholarPubMed
9.Duffy, PE, Tennyson, UM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson’s disease. J Neuropath Exp Neurol 1965; 24: 398–414.CrossRefGoogle Scholar
10.Itoh, T, Momma, Y, Ogasawara, N. An electron microscopic study on atypical presenile dementia with numerous Lewy bodies in the cerebral cortex. Folia Psychiatr Neurol Jpn 1982; 36:99–106.Google ScholarPubMed
11.Goldman, JE, Yen, SH, Chiu, F-C, Peress, NS. Lewy bodies of Parkinson’s disease contain neurofilament antigen. Science 1983; 221: 1082–1084.CrossRefGoogle Scholar
12.Sternberger, LA, Sternberger, NA. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA, 1983; 80: 6126–6130.CrossRefGoogle ScholarPubMed
13.Ikeda, K, Hori, A, Bode, G. Progressive dementia with “diffuse Lewy-type inclusions” in cerebral cortex. A case report. Arch Psychiatr Nervenkr 1980; 228: 243–248.CrossRefGoogle ScholarPubMed
14.Eggertson, DE, Sima, AAF. Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect? Arch Neurol 1986; 43: 524–527.CrossRefGoogle ScholarPubMed
15.Lindvall, O, Bjorklund, A, Divac, I. Organization of mesencephalic dopamin neurons projecting to neocortex and septum. In Costa, E and Gessa, GL eds. Advances in Biochemical Psychopharma-cology Vol. 16, New York, Raven Press, New York, 1977, pp 39–46.Google Scholar
16.Javoy-Agid, F, Agid, Y. Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 1980; 30: 1326–1330.CrossRefGoogle ScholarPubMed
17.Lindvall, O, Bjorklund, A, Moore, RY, et al. Mesencephalic dopamine neurons projecting to the neocortex. Brain Res 1974; 81: 325–331.CrossRefGoogle Scholar
18.Horoupian, DS, Wisniewski, H. Neurofilamentous hyperplasia in inferior olivary hypertrophy. J Neuropath Exp Neurol 1971; 30: 571–582.CrossRefGoogle ScholarPubMed
19.Forno, LS. Reaction of the substantia nigra to massive basal ganglia infarction. Acta Neuropath (Berl) 1983 62: 96–102.CrossRefGoogle ScholarPubMed
20.Yagishita, S, Itoh, Y, Nakano, T. Hypertrophy of the olivary nucleus. An ultrastructural study. Acta Neuropath (Berl) 1986 69: 132–138.CrossRefGoogle ScholarPubMed
21.Forno, LS, Sternberger, LA, Sternberger, NA, et al. Reaction of Lewy bodies with antibodies to phosphorylated and non-phos-phorylated neurofilaments. Neuroscience Letter 1986; 64: 253–258.CrossRefGoogle ScholarPubMed